A pilot study to plan a protocol for the clinical trial evaluating the efficacy of Rikkunshito for patients after total gastrectomy
Not Applicable
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000024364
- Lead Sponsor
- Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1. Synchronous or metachronous cancer 2. Reduced oral intake 3. Past gastrointestinal surgery 4. Preoperative chemotherapy 5. Administration of Rikkunshito ingredients before surgery 6. Unstable angina or myocardial infarction within six months 7. Pulmonary disease treated with continuous oxygen 8. Hemorrhagic tendency 9. Diabetes mellitus 10. Systemic treatment with corticosteroids 11. Pregnancy, breast-feeding, or contemplating pregnancy. 12. Mental disorder that affects informed consent or study protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight loss at three months after surgery
- Secondary Outcome Measures
Name Time Method Medication compliance of Rikkunshito Adverse events associated with Rikkunshito Quality of life score Plasma glucagon-like peptide-1